Sage Mountain Advisors LLC Eli Lilly & CO Transaction History

Sage Mountain Advisors LLC

$1.33 Billion
Q1 2025

A detailed history of Sage Mountain Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sage Mountain Advisors LLC holds 5,705 shares of LLY stock, worth $4.26 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

5,705

Previous 5,434 4.99%

Holding current value

$4.26 Million

Previous $4.2 Million 12.3%

% of portfolio

0.35%

Previous 0.31%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	BUY	$725.72 - $929.72 $196,670 - $251,954	271 Added 4.99%	5,705 $4.71 Million
Q4 2024 Feb 07, 2025	BUY	$727.2 - $932.06 $271,972 - $348,590	374 Added 7.39%	5,434 $4.2 Million
Q3 2024 Oct 29, 2024	BUY	$772.14 - $960.02 $152,883 - $190,083	198 Added 4.07%	5,060 $4.48 Million
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $447,969 - $561,786	618 Added 14.56%	4,862 $4.4 Million
Q1 2024 Apr 23, 2024	SELL	$592.2 - $792.28 $115,479 - $154,494	-195 Reduced 4.39%	4,244 $3.3 Million
Q4 2023 Feb 01, 2024	BUY	$525.19 - $619.13 $141,801 - $167,165	270 Added 6.48%	4,439 $2.59 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $89,548 - $123,455	206 Added 5.2%	4,169 $2.24 Million
Q2 2023 Jul 24, 2023	SELL	$350.74 - $468.98 $32,969 - $44,084	-94 Reduced 2.32%	3,963 $1.86 Million
Q1 2023 Apr 25, 2023	BUY	$310.63 - $364.82 $743,337 - $873,014	2,393 Added 143.81%	4,057 $1.39 Million
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $17,363 - $20,232	54 Added 3.35%	1,664 $608,000
Q3 2022 Oct 31, 2022	SELL	$296.48 - $337.87 $30,833 - $35,138	-104 Reduced 6.07%	1,610 $521,000
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $11,427 - $13,418	-41 Reduced 2.34%	1,714 $556,000
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $3,755 - $4,666	-16 Reduced 0.9%	1,755 $503,000
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $23,159 - $28,741	103 Added 6.18%	1,771 $489,000
Q3 2021 Nov 01, 2021	BUY	$221.6 - $272.71 $93,736 - $115,356	423 Added 33.98%	1,668 $385,000
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $27,443 - $35,498	152 Added 13.91%	1,245 $286,000
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $179,601 - $232,502	1,093 New	1,093 $204,000

Others Institutions Holding LLY

# of Institutions

4,389

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $710B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Mountain Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Mountain Advisors LLC with notifications on news.

Account

Sage Mountain Advisors LLC Eli Lilly & CO Transaction History